[Antiviral effect of various oligonucleotide derivatives, complementary to tick-born encephalitis virus RNA]. 1994

T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov

Antiviral effect of two nucleotides complementary to tick-borne encephalitis (TBE) virus genome and their derivatives was compared to that of noncomplementary oligonucleotides. All the tested reagents influenced TBE multiplication in cell culture, this manifesting by various degrees of suppression of the cytopathic effect of the virus. Intact oligonucleotides, both complementary and noncomplementary to TBE, reduced virus titer by 2-4 orders, whatever the concentration of oligonucleotide. In some experiments a higher virus-inhibiting effect of complementary oligonucleotides (by 3-4 orders) was observed vs. noncomplementary (by 1-2 orders). Moreover, different oligonucleotide derivatives suppressed virus multiplication in porcine embryo kidney cell culture. In parallel with investigation of virus-inhibitory effect of oligonucleotides in cell culture, their effects on the synthesis of virus-specific and cellular proteins was studied. Screening of oligonucleotide derivatives by capacity to suppress biosynthesis and multiplication of virus in cell culture showed the highest efficacy of reaction-capable and cholesterol derivatives.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004669 Encephalitis Viruses, Tick-Borne A subgroup of the genus FLAVIVIRUS that causes encephalitis and hemorrhagic fevers and is found in eastern and western Europe and the former Soviet Union. It is transmitted by TICKS and there is an associated milk-borne transmission from viremic cattle, goats, and sheep. Hemorrhagic Fever Virus, Omsk,Kyasanur Forest disease virus,Langat virus,Louping ill virus,Omsk hemorrhagic fever virus,Powassan virus,Al-Khurma Hemorrhagic Fever Virus,Al-Khurma virus,Al-Khurma virus (ALKV),Alkhurma Hemorrhagic Fever Virus,Alkhurma virus,Alkhurma virus (ALKV),Encephalitis Virus, Tick-Borne,Tick-Borne Encephalitis Virus,Tick-Borne Encephalitis Viruses,Viruses, Tick-Borne Encephalitis,Al Khurma Hemorrhagic Fever Virus,Al Khurma virus,Al Khurma virus (ALKV),Encephalitis Virus, Tick Borne,Encephalitis Viruses, Tick Borne,Louping ill viruses,Tick Borne Encephalitis Virus,Tick Borne Encephalitis Viruses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov
January 1988, Doklady Akademii nauk SSSR,
T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov
June 2001, La Revue de medecine interne,
T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov
March 2019, Molecules (Basel, Switzerland),
T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov
January 1989, Doklady Akademii nauk SSSR,
T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov
January 1961, Problems of virology,
T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov
March 1972, Journal of molecular biology,
T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov
November 2014, Journal of clinical microbiology,
T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov
January 2001, Voprosy virusologii,
T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov
January 1961, Voprosy virusologii,
T V Frolova, and N Iu Nomokonova, and V M Roĭkhel', and G I Fokina, and V V Pogodkina, and V V Vlasov
October 1995, Antiviral research,
Copied contents to your clipboard!